T. Otto

Phase II trial of titanocene dichloride in advanced renal-cell carcinoma

G. Lümmen, H. Sperling, Hans Luboldt et al. · Cancer Chemotherapy and Pharmacology · 1998 · 230 citations

Urology, Titanocene Dichloride, Genitourinary Cancer +5

A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-Guerin

S. Krege, G. Giani, Renate Meyer et al. · The Journal of Urology · 1996 · 196 citations

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Maciej Kwiatkowski, Franz Recker, Timo Piironen et al. · Urology · 1998 · 129 citations

Urology, Medicine, Pathology +5

Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned α₁‐adrenoceptor subtypes and in human prostate

Martin C. Michel, Burghard Grübbel, K Taguchi et al. · Journal of Autonomic Pharmacology · 1996 · 114 citations

Molecular Pharmacology, Urology, Human Prostate +12

Principles of Multisensory Behavior

T. Otto, Brice Dassy, Pascal Mamassian · Journal of Neuroscience · 2013 · 111 citations · Full text